-
1
-
-
0033515023
-
Dopamine beta-hydroxylase deficiency impairs cellular immunity
-
Alaniz R.C., Thomas S.A., Perez-Melgosa M., Mueller K., Farr A.G., Palmiter R.D., Wilson C.B. Dopamine beta-hydroxylase deficiency impairs cellular immunity. Proc. Natl Acad. Sci. USA 1999, 96:2274-2278.
-
(1999)
Proc. Natl Acad. Sci. USA
, vol.96
, pp. 2274-2278
-
-
Alaniz, R.C.1
Thomas, S.A.2
Perez-Melgosa, M.3
Mueller, K.4
Farr, A.G.5
Palmiter, R.D.6
Wilson, C.B.7
-
2
-
-
0035986765
-
Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia
-
Bilici M., Cakirbay H., Guler M., Tosun M., Ulgen M., Tan U. Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia. Int. J. Neurosci. 2002, 112:817-828.
-
(2002)
Int. J. Neurosci.
, vol.112
, pp. 817-828
-
-
Bilici, M.1
Cakirbay, H.2
Guler, M.3
Tosun, M.4
Ulgen, M.5
Tan, U.6
-
3
-
-
77956598675
-
Update in serotonin and bone
-
Bliziotes M. Update in serotonin and bone. J. Clin. Endocrinol. Metab. 2010, 95:4124-4132.
-
(2010)
J. Clin. Endocrinol. Metab.
, vol.95
, pp. 4124-4132
-
-
Bliziotes, M.1
-
4
-
-
0033990293
-
Bone histomorphometric and biomechanical abnormalities in mice homozygous for deletion of the dopamine transporter gene
-
Bliziotes M., McLoughlin S., Gunness M., Fumagalli F., Jones S.R., Caron M.G. Bone histomorphometric and biomechanical abnormalities in mice homozygous for deletion of the dopamine transporter gene. Bone 2000, 26:15-19.
-
(2000)
Bone
, vol.26
, pp. 15-19
-
-
Bliziotes, M.1
McLoughlin, S.2
Gunness, M.3
Fumagalli, F.4
Jones, S.R.5
Caron, M.G.6
-
5
-
-
0036735166
-
Optimal dosing of atypical antipsychotics in adults: a review of the current evidence
-
Citrome L., Volavka J. Optimal dosing of atypical antipsychotics in adults: a review of the current evidence. Harv. Rev. Psychiatry 2002, 10:280-291.
-
(2002)
Harv. Rev. Psychiatry
, vol.10
, pp. 280-291
-
-
Citrome, L.1
Volavka, J.2
-
6
-
-
38949152272
-
The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation
-
Collet C., Schiltz C., Geoffroy V., Maroteaux L., Launay J.M., de Vernejoul M.C. The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation. FASEB J. 2008, 22:418-427.
-
(2008)
FASEB J.
, vol.22
, pp. 418-427
-
-
Collet, C.1
Schiltz, C.2
Geoffroy, V.3
Maroteaux, L.4
Launay, J.M.5
de Vernejoul, M.C.6
-
7
-
-
0032715155
-
Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes
-
Cornish J., Callon K.E., Lin C.Q., Xiao C.L., Mulvey T.B., Cooper G.J., Reid I.R. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am. J. Physiol. 1999, 277:E779-E783.
-
(1999)
Am. J. Physiol.
, vol.277
-
-
Cornish, J.1
Callon, K.E.2
Lin, C.Q.3
Xiao, C.L.4
Mulvey, T.B.5
Cooper, G.J.6
Reid, I.R.7
-
8
-
-
18744376564
-
Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo
-
Cornish J., Callon K.E., Bava U., Lin C., Naot D., Hill B.L., Grey A.B., Broom N., Myers D.E., Nicholson G.C., et al. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J. Endocrinol. 2002, 175:405-415.
-
(2002)
J. Endocrinol.
, vol.175
, pp. 405-415
-
-
Cornish, J.1
Callon, K.E.2
Bava, U.3
Lin, C.4
Naot, D.5
Hill, B.L.6
Grey, A.B.7
Broom, N.8
Myers, D.E.9
Nicholson, G.C.10
-
9
-
-
54349086815
-
Modulation of osteoclastogenesis by fatty acids
-
Cornish J., MacGibbon A., Lin J.-M., Watson M., Callon K.E., Tong P.C., Dunford J.E., van der Does Y., Williams G.A., Grey A.B., et al. Modulation of osteoclastogenesis by fatty acids. Endocrinology 2008, 149:5688-5695.
-
(2008)
Endocrinology
, vol.149
, pp. 5688-5695
-
-
Cornish, J.1
MacGibbon, A.2
Lin, J.-M.3
Watson, M.4
Callon, K.E.5
Tong, P.C.6
Dunford, J.E.7
van der Does, Y.8
Williams, G.A.9
Grey, A.B.10
-
10
-
-
0142244688
-
Schizophrenia
-
Freedman R. Schizophrenia. N. Engl. J. Med. 2003, 349:1738-1749.
-
(2003)
N. Engl. J. Med.
, vol.349
, pp. 1738-1749
-
-
Freedman, R.1
-
11
-
-
0035095485
-
Lysophosphatidic acid is an osteoblast mitogen whose proliferative actions involve G(i) proteins and protein kinase C, but not p42/44 mitogen-activated protein kinases
-
Grey A., Banovic T., Naot D., Hill B., Callon K., Reid I., Cornish J. Lysophosphatidic acid is an osteoblast mitogen whose proliferative actions involve G(i) proteins and protein kinase C, but not p42/44 mitogen-activated protein kinases. Endocrinology 2001, 142:1098-1106.
-
(2001)
Endocrinology
, vol.142
, pp. 1098-1106
-
-
Grey, A.1
Banovic, T.2
Naot, D.3
Hill, B.4
Callon, K.5
Reid, I.6
Cornish, J.7
-
12
-
-
33645995104
-
Serotonin and fluoxetine modulate bone cell function in vitro
-
Gustafsson B.I., Thommesen L., Stunes A.K., Tommeras K., Westbroek I., Waldum H.L., Slordahl K., Tamburstuen M.V., Reseland J.E., Syversen U. Serotonin and fluoxetine modulate bone cell function in vitro. J. Cell. Biochem. 2006, 98:139-151.
-
(2006)
J. Cell. Biochem.
, vol.98
, pp. 139-151
-
-
Gustafsson, B.I.1
Thommesen, L.2
Stunes, A.K.3
Tommeras, K.4
Westbroek, I.5
Waldum, H.L.6
Slordahl, K.7
Tamburstuen, M.V.8
Reseland, J.E.9
Syversen, U.10
-
13
-
-
33645669475
-
Long-term serotonin administration leads to higher bone mineral density, affects bone architecture, and leads to higher femoral bone stiffness in rats
-
Gustafsson B.I., Westbroek I., Waarsing J.H., Waldum H., Solligard E., Brunsvik A., Dimmen S., van Leeuwen J.P., Weinans H., Syversen U. Long-term serotonin administration leads to higher bone mineral density, affects bone architecture, and leads to higher femoral bone stiffness in rats. J. Cell. Biochem. 2006, 97:1283-1291.
-
(2006)
J. Cell. Biochem.
, vol.97
, pp. 1283-1291
-
-
Gustafsson, B.I.1
Westbroek, I.2
Waarsing, J.H.3
Waldum, H.4
Solligard, E.5
Brunsvik, A.6
Dimmen, S.7
van Leeuwen, J.P.8
Weinans, H.9
Syversen, U.10
-
14
-
-
0029088593
-
Decreased bone mineral density in medicated psychiatric patients
-
Halbreich U., Rojanksy N., Palter S., Hreshchyshyn M., Kreeger J., Bakhai Y., Rosan R. Decreased bone mineral density in medicated psychiatric patients. Psychosom. Med. 1995, 57:485-491.
-
(1995)
Psychosom. Med.
, vol.57
, pp. 485-491
-
-
Halbreich, U.1
Rojanksy, N.2
Palter, S.3
Hreshchyshyn, M.4
Kreeger, J.5
Bakhai, Y.6
Rosan, R.7
-
15
-
-
0030198569
-
Phenothiazines are potent inhibitors of osteoclastic bone resorption
-
Hall T.J., Nyugen H., Schaeublin M., Michalsky M., Missbach M. Phenothiazines are potent inhibitors of osteoclastic bone resorption. Gen. Pharmacol. 1996, 27:845-848.
-
(1996)
Gen. Pharmacol.
, vol.27
, pp. 845-848
-
-
Hall, T.J.1
Nyugen, H.2
Schaeublin, M.3
Michalsky, M.4
Missbach, M.5
-
16
-
-
33846947984
-
Risk of hip fracture in patients with a history of schizophrenia
-
Howard L., Kirkwood G., Leese M. Risk of hip fracture in patients with a history of schizophrenia. Br. J. Psychiatry 2006, 190:129-134.
-
(2006)
Br. J. Psychiatry
, vol.190
, pp. 129-134
-
-
Howard, L.1
Kirkwood, G.2
Leese, M.3
-
17
-
-
28844479756
-
Risk of hip/femur fractures in patients using antipsychotics
-
Hugenholtz G.W.K., Heerdink E.R., van Staa T.P., Nolena W.A., Egberts A.C.G. Risk of hip/femur fractures in patients using antipsychotics. Bone 2005, 37:864-870.
-
(2005)
Bone
, vol.37
, pp. 864-870
-
-
Hugenholtz, G.W.K.1
Heerdink, E.R.2
van Staa, T.P.3
Nolena, W.A.4
Egberts, A.C.G.5
-
18
-
-
0033367495
-
Switch from neuroleptics to clozapine does not influence pituitary-gonadal axis hormone levels in male schizophrenic patients
-
Markianos M., Hatzimanolis J., Lykouras L. Switch from neuroleptics to clozapine does not influence pituitary-gonadal axis hormone levels in male schizophrenic patients. Eur. Neuropsychopharmacol. 1999, 9:533-536.
-
(1999)
Eur. Neuropsychopharmacol.
, vol.9
, pp. 533-536
-
-
Markianos, M.1
Hatzimanolis, J.2
Lykouras, L.3
-
19
-
-
4243057297
-
A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology
-
McGrath J., Saha S., Welham J., El Saadi O., MacCauley C., Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med. 2004, 2:13.
-
(2004)
BMC Med.
, vol.2
, pp. 13
-
-
McGrath, J.1
Saha, S.2
Welham, J.3
El Saadi, O.4
MacCauley, C.5
Chant, D.6
-
20
-
-
38449096127
-
Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms
-
O'Sullivan S., Naot D., Callon K., Porteous F., Horne A., Wattie D., Watson M., Cornish J., Browett P., Grey A. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms. J. Bone Miner. Res. 2007, 22:1679-1689.
-
(2007)
J. Bone Miner. Res.
, vol.22
, pp. 1679-1689
-
-
O'Sullivan, S.1
Naot, D.2
Callon, K.3
Porteous, F.4
Horne, A.5
Wattie, D.6
Watson, M.7
Cornish, J.8
Browett, P.9
Grey, A.10
-
21
-
-
67649194773
-
Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study
-
Pouwels S., van Staa T.P., Egberts A.C.G., Leufkens H.G.M., Cooper C., de Vries F. Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study. Osteoporos. Int. 2009, 20:1499-1506.
-
(2009)
Osteoporos. Int.
, vol.20
, pp. 1499-1506
-
-
Pouwels, S.1
van Staa, T.P.2
Egberts, A.C.G.3
Leufkens, H.G.M.4
Cooper, C.5
de Vries, F.6
-
22
-
-
43149117061
-
Relationships between fat and bone
-
Reid I.R. Relationships between fat and bone. Osteoporos. Int. 2008, 19:595-606.
-
(2008)
Osteoporos. Int.
, vol.19
, pp. 595-606
-
-
Reid, I.R.1
-
23
-
-
55649115291
-
Atypical antipsychotic drugs induce derangements in glucose homeostasis by acutely increasing glucagon secretion and hepatic glucose output in the rat
-
Smith G.C., Chaussade C., Vickers M., Jensen J., Shepherd P.R. Atypical antipsychotic drugs induce derangements in glucose homeostasis by acutely increasing glucagon secretion and hepatic glucose output in the rat. Diabetologica 2008, 51:2309-2317.
-
(2008)
Diabetologica
, vol.51
, pp. 2309-2317
-
-
Smith, G.C.1
Chaussade, C.2
Vickers, M.3
Jensen, J.4
Shepherd, P.R.5
-
24
-
-
70349423412
-
Clozapine and quetiapine acutely reduce glucagon-like peptide-1 production and increase glucagon release in obese rats: implications for glucose metabolism and food choice behaviour
-
Smith G.C., Vickers M.H., Cognard E., Shepherd P.R. Clozapine and quetiapine acutely reduce glucagon-like peptide-1 production and increase glucagon release in obese rats: implications for glucose metabolism and food choice behaviour. Schizophr. Res. 2009, 115:30-40.
-
(2009)
Schizophr. Res.
, vol.115
, pp. 30-40
-
-
Smith, G.C.1
Vickers, M.H.2
Cognard, E.3
Shepherd, P.R.4
-
25
-
-
0036847619
-
Leptin regulates bone formation via the sympathetic nervous system
-
Takeda S., Elefteriou F., Levasseur R., Liu X., Zhao L., Parker K.L., Armstrong D., Ducy P., Karsenty G. Leptin regulates bone formation via the sympathetic nervous system. Cell 2002, 111:305-317.
-
(2002)
Cell
, vol.111
, pp. 305-317
-
-
Takeda, S.1
Elefteriou, F.2
Levasseur, R.3
Liu, X.4
Zhao, L.5
Parker, K.L.6
Armstrong, D.7
Ducy, P.8
Karsenty, G.9
-
26
-
-
12344313055
-
Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth
-
Warden S.J., Robling A.G., Sanders M.S., Bliziotes M.M., Turner C.H. Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinology 2005, 146:685-693.
-
(2005)
Endocrinology
, vol.146
, pp. 685-693
-
-
Warden, S.J.1
Robling, A.G.2
Sanders, M.S.3
Bliziotes, M.M.4
Turner, C.H.5
-
27
-
-
67651148206
-
In vitro and in vivo effects of adiponectin on bone
-
Williams G.A., Wang Y., Callon K.E., Watson M., Lin J.-m., Lam J.B.B., Costa J.L., Orpe A., Broom N., Naot D., et al. In vitro and in vivo effects of adiponectin on bone. Endocrinology 2009, 150:3603-3610.
-
(2009)
Endocrinology
, vol.150
, pp. 3603-3610
-
-
Williams, G.A.1
Wang, Y.2
Callon, K.E.3
Watson, M.4
Lin, J.-M.5
Lam, J.B.B.6
Costa, J.L.7
Orpe, A.8
Broom, N.9
Naot, D.10
-
28
-
-
56349162283
-
Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum
-
Yadav V.K., Ryu J.H., Suda N., Tanaka K.F., Gingrich J.A., Schutz G., Glorieux F.H., Chiang C.Y., Zajac J.D., Insogna K.L., et al. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 2008, 135:825-837.
-
(2008)
Cell
, vol.135
, pp. 825-837
-
-
Yadav, V.K.1
Ryu, J.H.2
Suda, N.3
Tanaka, K.F.4
Gingrich, J.A.5
Schutz, G.6
Glorieux, F.H.7
Chiang, C.Y.8
Zajac, J.D.9
Insogna, K.L.10
-
29
-
-
69449083603
-
A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure
-
Yadav V.K., Oury F., Suda N., Liu Z.W., Gao X.B., Confavreux C., Klemenhagen K.C., Tanaka K.F., Gingrich J.A., Guo X.E., et al. A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 2009, 138:976-989.
-
(2009)
Cell
, vol.138
, pp. 976-989
-
-
Yadav, V.K.1
Oury, F.2
Suda, N.3
Liu, Z.W.4
Gao, X.B.5
Confavreux, C.6
Klemenhagen, K.C.7
Tanaka, K.F.8
Gingrich, J.A.9
Guo, X.E.10
|